This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Daubenberger, C. A. Articles by Pluschke, G. Search for Related Content PubMed PubMed Citation Articles by Daubenberger, C. A. Articles by Pluschke, G.

 Previous Article  |  Next Article 

Infection and Immunity, April 2003, p. 2173-2181, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2173-2181.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Identification and Characterization of a Conserved, Stage-Specific Gene Product of Plasmodium falciparum Recognized by Parasite Growth Inhibitory Antibodies

Claudia A. Daubenberger,^1* Diana Diaz,¹ Marija Curcic,¹ Markus S. Mueller,¹ Tobias Spielmann,¹ Ulrich Certa,² Joachim Lipp,³ and Gerd Pluschke¹

Molecular Immunology, Swiss Tropical Institute, 4002 Basel,¹ Hoffmann-La Roche Ltd., Roche Genetics, 4070 Basel, Switzerland,² Vienna International Research Cooperation Center, Department of Vascular Biology and Thrombosis Research, University of Vienna, A1235 Vienna, Austria³

Received 7 October 2002/ Returned for modification 25 November 2002/ Accepted 23 December 2002

We have identified a novel conserved protein of Plasmodium falciparum, designated D13, that is stage-specifically expressed in asexual blood stages of the parasite. The predicted open reading frame (ORF) D13 contains 863 amino acids with a calculated molecular mass of 99.7 kDa and displays a repeat region composed of pentapeptide motives. Northern blot analysis with lysates of synchronized blood stage parasites showed that D13 is highly expressed at the mRNA level during schizogony. The first N'-terminal 138 amino acids of D13 were expressed in Escherichia coli and the purified protein was used to generate anti-D13 monoclonal antibodies (MAbs). Using total lysates of blood stage parasites and Western blot analysis, these MAbs stained one single band of 100 kDa, corresponding to the predicted molecular mass of ORF D13. Western blot analysis demonstrated further that D13 is expressed during schizogony, declines rapidly in early ring stages and is undetectable in trophozoites. D13 protein is localized in individual merozoites in a distinct area, as demonstrated by indirect immunofluorescence analysis. After subcellular fractionation, D13 was confined to the pelleted fraction of the parasite lysate and its extraction by alkaline carbonate buffer treatment indicated that D13 is not a membrane-integral protein. Inclusion of certain anti-D13 MAbs into in vitro cultures of blood stage parasites resulted in considerable reduction in parasite growth. The N'-terminal domain encompassing 158 amino acids is 94 and 95%, respectively, identical at the amino acid level between Plasmodium knowlesi, Plasmodium yoelii, and P. falciparum. In summary, we describe a novel stage-specifically expressed, highly conserved gene product of P. falciparum that is recognized by parasite growth inhibitory antibodies.

---

* Corresponding author. Mailing address: Molecular Immunology, Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland. Phone: 41 61 2848217. Fax: 41 61 2718654. E-mail: Claudia.Daubenberger{at}unibas.ch.

Editor: W. A. Petri, Jr.

---

Infection and Immunity, April 2003, p. 2173-2181, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2173-2181.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.